Comprehensive Genomic Landscape Across Histopathological Stages of Lung Adenocarcinoma: A Retrospective Cross‐Sectional Study

Xueting Hu, Yongsheng Huang, Yuyan Cao, Wenjian Wang, Jiawen Wang, Kexi Wang, Duoguang Wu, Sha Fu, Minghui Wang, Kefeng Wang
MedComm · Wiley · 2026-11-17 · DOI: 10.1002/mco2.71150

Abstract

ABSTRACT The genomic features associated with the histopathological spectrum from precursor glandular lesions to invasive lung adenocarcinoma remain incompletely characterized. In this retrospective cross‐sectional study, we performed targeted sequencing of 823 resected lesions from 823 patients, including 149 precursor glandular lesions (11 atypical adenomatous hyperplasia [AAH] and 138 adenocarcinoma in situ [AIS]), 252 minimally invasive adenocarcinoma (MIA), and 422 invasive adenocarcinoma (IAC). EGFR mutation frequency increased across precursor lesions, MIA, and IAC (44%, 57%, and 65%), whereas ERBB2 decreased (20%, 13%, and 6%); TP53 was markedly enriched in IAC (3%, 6%, and 35%). Cell‐cycle and homologous recombination repair (HRR) pathway alterations were likewise more frequent in IAC and in Grade 3 tumors. Solid nodules showed higher TP53, cell‐cycle, and HRR alteration frequencies than ground‐glass‐predominant lesions. IAC displayed prominent tobacco‐associated single‐base substitutions 4 (SBS4) and APOBEC‐associated SBS2 signatures, whereas MIA signatures showed lower similarity to canonical COSMIC signatures. Smoking was associated with a distinct genomic profile and higher tumor mutational burden (TMB). TMB and PD‐L1 tumor proportion score varied according to gene mutation status. High TMB and KRAS/STK11/KEAP1‐related mutation groups were associated with poorer survival. These findings delineate histology‐associated genomic patterns across the lung adenocarcinoma spectrum without implying direct temporal evolution.

Read at publisher →

Similar articles